Results 21 to 30 of about 52,279 (291)

Current Mechanistic Understandings of Lymphedema and Lipedema: Tales of Fluid, Fat, and Fibrosis

International Journal of Molecular Sciences, 2022
Lymphedema and lipedema are complex diseases. While the external presentation of swollen legs in lower-extremity lymphedema and lipedema appear similar, current mechanistic understandings of these diseases indicate unique aspects of their underlying ...
Bailey H. Duhon, T. Phan, Shannon L. Taylor, R. Crescenzi, J. Rutkowski   +4 more
semanticscholar   +1 more source

Combined Treatment with Lymphaticovenular Anastomosis and Ethanol Sclerotherapy for Cystic Lymphangioma in a Limb

Plastic and Reconstructive Surgery, Global Open, 2022
Summary:. Several treatment options, including sclerotherapy and surgical excision, are available for the management of cystic lymphangioma. Lymphaticovenular anastomosis (LVA) has recently garnered attention in the field of microsurgery as a minimally ...
Shuhei Yoshida, MD, PhD, Hirofumi Imai, MD, Solji Roh, MD, Toshiro Mese, MD, Isao Koshima, MD, PhD   +4 more
doaj   +1 more source

Impact of Anesthetic Cream and Vibration on Injection Pain in Lymphedema. [PDF]

Plast Reconstr Surg Glob Open
Background:. Although lymphaticovenous anastomosis (LVA) is commonly performed under general anesthesia, some centers perform it under awake, local anesthesia.
Iwanaga Y, Mihara M, Hara H.
europepmc   +2 more sources

Cystic Lymphatic Malformation with Lymphedema Treated by Lymphaticovenular Anastomosis Combined with Ethanol Sclerotherapy

Plastic and Reconstructive Surgery, Global Open, 2023
The incidence of cystic lymphatic malformation (CL) in an extremity is very rare. CL can be a cause of lymphedema in a lower limb. The most effective treatment for CL is sclerotherapy or excision; however, these treatments have the potential to cause ...
Shuhei Yoshida, MD, PhD, Hirofumi Imai, MD, Solji Roh, MD, Toshiro Mese, MD, Isao Koshima, MD, PhD   +4 more
doaj   +1 more source

The American Venous Forum, American Vein and Lymphatic Society and the Society for Vascular Medicine expert opinion consensus on lymphedema diagnosis and treatment

Phlebology, 2022
Background Lymphedema imposes a significant economic and social burden in modern societies. Controversies about its risk factors, diagnosis, and treatment permeate the literature.
F. Lurie, R. Malgor, T. Carman, S. Dean, M. Iafrati, N. Khilnani, N. Labropoulos, T. Maldonado, P. Mortimer, T. O'donnell, J. Raffetto, S. Rockson, A. Gasparis   +12 more
semanticscholar   +1 more source

TGF‐β1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation

Clinical and Translational Medicine, 2022
Background Secondary lymphedema is a common complication of cancer treatment, and previous studies have shown that the expression of transforming growth factor‐beta 1 (TGF‐β1), a pro‐fibrotic and anti‐lymphangiogenic growth factor, is increased in this ...
J. Baik, Hyeung Ju Park, Raghu P. Kataru, I. Savetsky, Catherine L. Ly, Jinyeon Shin, Elizabeth M. Encarnacion, Michele Cavali, M. Klang, E. Riedel, M. Coriddi, Joseph H. Dayan, B. Mehrara   +12 more
semanticscholar   +1 more source

Surgical Treatment and Rehabilitation Strategies for Upper and Lower Extremity Lymphedema: A Comprehensive Review

Medicina, 2022
Lymphedema is a chronic disabling condition affecting a growing number of patients worldwide. Although lymphedema is not life-threatening, several reports underlined detrimental consequences in terms of distress, pain, functional impairment, and ...
A. de Sire, L. Losco, Lorenzo Lippi, Davide Spadoni, J. Kaciulyte, G. Sert, P. Ciamarra, M. Marcasciano, Roberto Cuomo, A. Bolletta, M. Invernizzi, E. Cigna   +11 more
semanticscholar   +1 more source

The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology.

Lymphology, 2020
This International Society of Lymphology (ISL) Consensus Document is the latest revision of the 1995 Document for the evaluation and management of peripheral lymphedema (1).
Consensus Document
semanticscholar   +1 more source

The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment

npj Breast Cancer, 2021
The impact of breast cancer-related lymphedema (BCRL) on long-term quality of life is unknown. The aim of this study was to investigate the impact of BCRL on health-related quality of life (HRQoL) up to 10 years after breast cancer treatment.
M. G. Jørgensen, N. Toyserkani, Frederik Hansen, A. Bygum, J. A. Sørensen   +4 more
semanticscholar   +1 more source

Lymphatic Microsurgical Preventive Healing Approach for the Primary Prevention of Lymphedema: A 4-Year Follow-Up

Plastic and Reconstructive Surgery, 2022
Background: Axillary lymph node dissection (ALND) remains the leading cause of lymphedema nationally, and there is still no cure for the disease. The lymphatic microsurgical preventive healing approach (LYMPHA) is a promising option for lymphedema ...
A. Levy, Alexander I. Murphy, Sherene Ishtihar, Anya Peysakhovich, B. Taback, R. Grant, J. Ascherman, S. Feldman, C. Rohde   +8 more
semanticscholar   +1 more source